Why the study?
Do statins reduce cardiovascular morbidity and mortality in patients with Type 2 diabetes?
Population
Patients with Type 2 diabetes
Comparison
Statins vs Placebo (as referenced in discussed trials)
Design
Review
Authors
Loading...
Supports statin use in T2D for CV risk reduction; confirms and extends RCT evidence on mortality and MI benefits.
Do statins reduce cardiovascular morbidity and mortality in patients with Type 2 diabetes?
This review summarizes the pathophysiological mechanisms of diabetic dyslipidemia and highlights robust clinical trial evidence supporting the routine use of statins to reduce macrovascular complications in patients with Type 2 diabetes.
Andrew J. Krentz (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: